Bibliografía
1. European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012;56(4):908-43.
2. Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 2018;67(1):358-80.
3. Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet 2018;391(10127):1301-14.
4. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol 2018;69(1):182-236.
5. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-36.
6. Baffy G, Brunt EM, Caldwell SH. Hepatocellular carcinoma in nonalcoholic fatty liver disease: an emerging menace. J Hepatol 2012;56:1384-91.
7. Schütte K, Schulz C, Poranzke J, et al. Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver. BMC Gastroenterol 2014;14:117.
8. Mohamad B, Shah V, Onyshchenko M, et al. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis. Hepatol Int 2016;10(4):632-9.
9. Giannini EG, Marenco S, Bruzzone L, et al. Hepatocellular carcinoma in patients without cirrhosis in Italy. Dig Liver Dis 2013;45(2):164-9.
10. Shimada M, Rikimaru T, Sugimachi K, et al. The importance of hepatic resection for hepatocellular carcinoma originating from nonfibrotic liver. J Am Coll Surg 2000;191(5):531-7.
11. Chang CH, Chau GY, Lui WY, et al. Long-term results of hepatic resection for hepatocellular carcinoma originating from noncirrhotic liver. Arch Surg 2004; 139 (3): 320-5.
12. Moya A, López-Andújar R, San Juan F, et al. Patrones de calidad en el manejo del carcinoma hepatocelular mediante resección hepática: criterios de selección y resultados en una unidad de referencia de cirugía hepatobiliar. Cir Esp 2004;76(2):101-6.
13. Faber W, Sharafi S, Stockmann M, et al. Patient age and extent of liver resection influence outcome of liver resection for hepatocellular carcinoma in non-cirrhotic liver. Hepatogastroenterology 2014;61(135):1925-30.
14. Faber W, Sharafi S, Stockmann M, et al. Long-term results of liver resection for hepatocellular carcinoma in noncirrhotic liver. Surgery 2013;153(4):510-7.
15. Zhou Y, Lei X, Wu L, et al. Outcomes of hepatectomy for nonchirrotics hepatocellular carcinoma: a systemic review. Surg Oncol 2014;23(4):236-42.
16. Nuñez O, Matilla A, Merino B, et al. Estudio descriptivo de la experiencia sobre carcinoma hepatocelular en hígado no cirrótico. Gastroenterol Hepatol 2011;34(5):322-8.
17. Díaz-González A, Forner A, Rodríguez de Lope C, et al. Nuevos retos en la investigación clínica del carcinoma hepatocellular. Rev Esp Enferm Dig 2016;8(108):485-93
18. Rodríguez de Lope C, Reig M, Matilla A, et al. Características clínicas del carcinoma hepatocelular en España. Comparación con el período 2008-2009 y análisis de las causas de diagnóstico fuera de los programas de detección. Análisis de 686 casos en 73 centros. Med Clin (Barc) 2017;149(2):61-71.
19. European Association for Study of Liver; Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol 2015;63(1):237-64.
20. Degos F, Perez P, Roche B, et al. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study). J Hepatol 2010;53:1013–21.
21. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994;20(1 Pt 1):15-20.
22. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996;24(2):289-93.
23. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954;7:462–503.
24. Dyson J, Jaques B, Chattopadyhay D, et al. Hepatocellular carcinoma: The impact of obesity, type 2 diabetes and a multidisciplinary team. J Hepatol 2014;60:110-7.
25. Kanwal F, JR Kramer, Duan Z, et al. Trends in the Burden of Nonalcoholic Fatty Liver disease in a United States Cohorts of Veterans. Clin Gastroenterol Hepatol 2016;14(2):301-8.
26. Schlesinger S, Aleksandrova K, Pischon T, et al. Diabetes mellitus, insulin treatment diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort. Ann Oncol 2013; 24:2449-55.
27. Trevisani F, Frigerio M, Santi V, et al. Hepatocellular carcinoma in non-cirrhotic liver: a reappraisal. Dig Liver Dis 2010;42(5):341-7.
28. Grazi GL, Cescon M, Ravaioli M, et al. Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for longs-term survival and tumour recurrence in a single center. Aliment Pharmacol Ther 2003;17(Suppl 2):119-29.
29. Yasui K, Hashimoto E, Komorizono Y, et al Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma. Clin Gastroenterol Hepatol 2011;9(5):428-33.
30. Leung C, Yeoh SW, Patrick D, et al. Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease. World J Gastroenterol 2015;21(4):1189-96.
31. Arnaoutakis DJ, Mavros MN, Shen F, et al. Recurrence patterns and prognostic factors in patients with hepatocellular carcinoma in noncirrhotic liver: a multi-institucional analysis. Ann Surg Oncol 2014;21:147-54.
32. Tampaki M, Savvanis S, Koskinas J. Impact of direct-acting antiviral agents on the development of hepatocellular carcinoma: evidence and pathophysiological issues. Ann Gastroenterol 2018;31(6):670-79.
33. Cabibbo G, Celsa C, Cammà C, Craxì A.Should we cure hepatitis C virus in patients with hepatocelular carcinoma while treating cancer? Liver Int 2018;38(12):2108-16.
34. Chiappini F, Gross-Goupil M, Saffroy R, et al. Microsatellite instability mutator phenotype in hepatocelular carcinoma in non-alcoholic and non-virally infected normal livers. Carcinogenesis 2004;25(4):541-7.
35. Di Martino M, Saba L, Bosco S, et al. Hepatocellular carcinoma (HCC) in non-cihrrotic liver: clinical, radiological and pathological findings. Eur Radiol 2014;24(7):1446-54.
36. Mergental H, Adam R, Ericzon BG, et al. Liver transplantation for unresectable hepatocellular carcinoma in normal livers. J Hepatol 2012;57(2):297-305.
37. Decaens T, Laurent A, Luciani A. Liver transplantation for hepatocellular carcinoma in non-cirrhotic livers regardless of the number and size of tumours? J Hepatol 2012;57(2):235-6.
38. Lang H, Sotiropoulos GC, Domland M, et al. Liver resection for hepatocellular carcinoma in non-cihrrotic liver without underlying viral hepatitis. Br J Surg 2005;92198-202.
39. Laurent C, Blanc JF, Nobili S, et al. Prognostic factors and long-term survival after hepatic resection for hepatocellular carcinoma originating from noncirrhotic liver. J Am Coll Surg 2005;201(5):656-62.
40. Wörns MA, Bosslet T, Victor A, et al. Prognostics factors and outcomes of patients with hepatocellular carcinoma in non-cirrhotic liver. Scand J Gastroenterol 2012;47(6):718-28.
41. Taura K, Ikai I, Hatano E, et al. Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients. Surgery 2007;142(5):685-94.
42. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrosis. N Engl J Med 1996; 334(11):693-9.
43. Clavien PA, Lesurtel M, Bossuyt PM, et al. OLT for HCC Consensus Group. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol 2012;13(1):e11-22.
44. Lubrano J, Huet E, Tsilividis B, et al. Long-term outcme of liver resection for hepatocellular carcinoma in noncirrhotic nonfibrotic liver with no viral heatitis or alcohol abuse. World J Surg 2008;32(1):104-9.